Ian Mann

Weatherden

Weatherden is a global integrated clinical consultancy and experts in scientific strategy and clinical development that is trusted by biopharma, funds, startups, spin-outs and nonprofits. We advise companies from the earliest stages on scientific strategy, translational medicine and clinical development, through to diligence prep and support for M&A. Our focus is on de-risking programmes early, optimising clinical, regulatory, and commercial pathways from discovery to market and accelerating the translation of novel science into life-changing medicines for patients. Blending more than 900 years' experience across the industry, we are invested in our clients' success, motivated by the opportunity to rapidly improve the chances for breakthrough therapies to tackle unmet clinical need. Combining an agile biotech mindset with the proven expertise of pharmaceutical drug discovery and development, we work at the cutting edge of clinical, scientific and technological innovation to maximise value, enhance patient outcomes and simplify paths to market.